Absence of clinically relevant interaction between sugammadex and aspirin on platelet aggregation and coagulation

被引：0
|
作者：
Kruithof, A. [1 ]
De Kam, P. J. [2 ]
El Galta, R. [3 ]
Burggraaf, J. [1 ]
Kluft, C. [4 ]
Fennema, H. [3 ]
Van Lierop, M. J. [3 ]
Mihara, K. [3 ]
Jagt-Smook, M. [3 ]
Moerland, M. [1 ]
机构：
[1] Ctr Human Drug Res, Leiden, Netherlands
[2] Merck, Whitehouse Stn, NJ USA
[3] MSD, Oss, Netherlands
[4] Good Biomarker Sci, Leiden, Netherlands
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2013年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1141 / 1142
页数：2
相关论文
共 50 条
  • [1] No clinically relevant interaction between sugammadex and aspirin on platelet aggregation and coagulation parameters
    de Kam, Pieter-Jan
    El Galta, Rachid
    Kruithof, Annelieke C.
    Fennema, Hein
    van Lierop, Marie-Jose
    Mihara, Katsuhiro
    Burggraaf, Jacobus
    Moerland, Matthijs
    Peeters, Pierre
    Troyer, Matthew D.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2013, 51 (12) : 976 - 985
  • [2] No clinically relevant interaction between sugammadex and heparin (enoxaparin and unfractionated heparin) on coagulation
    Kruithof, A.
    De Kam, P. J.
    El Galta, R.
    Moerland, M.
    Kluft, C.
    Van Lierop, M. J.
    Dennie, J.
    Troyer, M.
    Gutstein, D.
    Burggraaf, J.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 1091 - 1092
  • [3] Absence of a clinically relevant interaction between etanercept and digoxin
    Zhou, HH
    Parks, V
    Patat, A
    Le Coz, F
    Simcoe, D
    Korth-Bradley, J
    JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 44 (11): : 1244 - 1251
  • [4] Absence of a Clinically Relevant Pharmacokinetic Interaction Between Ambrisentan and Mycophenolate Mofetil
    Mandagere, A.
    Coar, B.
    Bird, S. W.
    Bingham, J.
    Boinpally, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
  • [5] Absence of clinically relevant pharmacokinetic interaction between ribavirin and tenofovir in healthy subjects
    Ramanathan, S
    Cheng, A
    Mittan, A
    Ebrahimi, R
    Kearney, BR
    JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 46 (05): : 559 - 566
  • [6] When the absence of an interaction can become clinically relevant
    Cattaneo, Dario
    Bernacchia, Dario
    Beltrami, Martina
    Resnati, Chiara
    Meraviglia, Paola
    Gervasoni, Cristina
    AIDS, 2021, 35 (08) : 1327 - 1328
  • [7] Anti-Platelet Therapy and Aspirin Resistance - Clinically and Chemically Relevant?
    Rafferty, M.
    Walters, M. R.
    Dawson, J.
    CURRENT MEDICINAL CHEMISTRY, 2010, 17 (36) : 4578 - 4586
  • [8] Anti-platelet effects of aspirin are modified by clopidogrel: Assessment of a clinically relevant interaction using short thrombelastography
    Hobson, A. R.
    Qureshi, Z.
    Banks, P.
    Curzen, N. P.
    HEART, 2008, 94 : A125 - A125
  • [9] ANTI-PLATELET EFFECTS OF ASPIRIN ARE MODIFIED BY CLOPIDOGREL: ASSESSMENT OF A CLINICALLY RELEVANT INTERACTION USING SHORT THROMBELASTOGRAPHY
    Hobson, A.
    Qureshi, Z.
    Banks, P.
    Curzen, N.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2009, 105 : 50 - 50
  • [10] The interaction between the preferential COX-2 inhibitor meloxicam and aspirin is statistically significant but not clinically relevant
    Fleuren, HWHA
    Gunnewiek, JMTK
    de Metz, M
    Vollaard, EJ
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 59 (01) : 128 - 129
12345